Update on Oral SERDs for Estrogen Receptor-Positive MBC
Selective estrogen receptor degraders (SERDs) are a type of hormone therapy used to treat estrogen receptor-positive (ER+) MBC. Oral SERDs are taken by mouth....
Read MoreMBC News from 2021 AACR Meeting
The American Association for Cancer Research (AACR) is the largest cancer research organization dedicated to accelerating research to prevent and cure cancer. The...
Read MoreVideos About Breast Cancer Clinical Trials
Many of our Metastatic Trial Search partners provide information about clinical trials to help people in the metastatic breast cancer community understand all...
Read MoreLymphodepletion in Cancer Immunotherapy
Adoptive cell therapy (ACT) is a category of immunotherapy currently being studied in clinical trials to treat metastatic breast cancer. Types of ACT...
Read MoreWhere You Can Find Current MBC Research
Staying informed on current research can help you learn about the most up-to-date options for cancer management, make informed decisions, and gain control over...
Read MoreLocal Therapies for Liver Mets
Liver mets — also called hepatic metastases — occur in up to fifty percent of people living with stage IV breast cancer. Historically, using local...
Read MoreY-90 Internal Radiation Therapy for Liver Mets
Yttrium-90 (Y-90) is a type of local treatment for liver mets that delivers radiation therapy by inserting Y-90 beads into the tumor. Y-90 is a chemical that...
Read MoreSt. Gallen International Breast Cancer Conference 2021
The St. Gallen International Breast Cancer Conference was held virtually this year from March 17 – 20, 2021, and featured talks about many metastatic breast...
Read MoreSpotlight on New Partners
Metastatic Trial Search partners are organizations that host Metastatic Trial Search on their websites to bring patient-centered trial matching to their...
Read MoreSEARCH OUR SITE
for past articles or specific information.